Company Monitoring Page for Ipsen

latest headlines for company on cafepharma

FDA approves Cabometyx for liver cancer
BioCentury
Mon, 01/14/19 - 11:59 pm
Tags:
Exelixis, Ipsen, Cabometyx, liver cancer, FDA
With New HQ, Ipsen to Rapidly Expand North American Presence
BioSpace
Sat, 11/17/18 - 12:59 pm
Tags:
Ipsen, Kendall Square
Exelixis and Ipsen Announce Positive CHMP Opinion for Cabometyx in Previously Treated Hepatocellular Carcinoma
CP WIre
Fri, 09/21/18 - 10:02 am
Tags:
Exelixis, Ipsen, Cabometyx, hepatocellular carcinoma
Fri, 09/21/18 - 09:42 am
Tags:
Exelixis, Ipsen, Cabometyx, hepatocellular carcinoma
Canada Approves Cabometyx for Adults with Previously Treated Advanced Renal Cell Carcinoma
CP Wire
Wed, 09/19/18 - 11:27 am
Tags:
Exelixis, Cabometyx, Takeda, Canada, Japan, Ipsen, renal cell carcinoma
Wed, 09/19/18 - 09:16 am
Tags:
Exelixis, Ipsen, Cabometyx
Relocating its US HQ to Boston, French pharma Ipsen to add 250 jobs
Endpoints
Thu, 06/7/18 - 10:50 pm
Tags:
biotech, Boston, Kendall Square, Ipsen, hirings
Thu, 05/17/18 - 09:17 am
Tags:
Exelixis, Ipsen, Cabometyx, advanced renal cell carcinoma, renal cell carcinoma
Ipsen focuses on oncology to keep growing
GoInPharma
Mon, 09/18/17 - 09:24 am
Tags:
Ipsen, oncology, Xermelo, kidney cancer
Ipsen wins approval for gastroenteropancreatic neuroendocrine tumor drug
Mass Device
Tue, 07/4/17 - 11:05 pm
Tags:
Ipsen, gastroenteropancreatic neuroendocrine tumor, Somatuline
Sanofi Sells 5 Over-the-Counter Drugs for $88M
Investopedia
Tue, 02/14/17 - 09:20 am
Tags:
Sanofi, OTC, M&A, Ipsen
France's Ipsen to buy Merrimack's pancreatic cancer drug, assets in $1 bln deal
Yahoo/Reuters
Mon, 01/9/17 - 09:54 am
Tags:
Ipsen, France, Merrimack Pharmaceuticals, pancreatic cancer, Onivyde
Exelixis and its partner Ipsen announce phase 3 trial results of CABOMETYX™ (cabozantinib) tablets demonstrating significant overall survival benefit for previously treated patients with advanced renal cell carcinoma presented at ASCO
Yahoo
Sun, 06/5/16 - 11:59 am
Tags:
Exelixix, Ipsen, clinical trials, advanced renal cell carcinoma, Cabometyx, ASCO 2016
Ipsen to Step Up Deal-Making, Scout for New Cancer Products
Bloomberg
Tue, 01/19/16 - 04:27 pm
Tags:
Ipsen, M&A, oncology
Ipsen on a hiring binge in U.S. to prep for new Somatuline marketing push
Fierce Pharma Marketing
Wed, 11/26/14 - 11:50 am
Tags:
Ipsen, Somatuline, hirings, drug launches
Nestle’s Galderma Deepens Ipsen Alliance for Wrinkle Smoother
Bloomberg
Fri, 07/11/14 - 08:32 am
Tags:
Nestle, Galderma, Ipsen, Dysport, Azzalure
China Drug Probe Leads to Tougher Market, Ipsen CEO Says
Bloomberg
Fri, 08/30/13 - 09:28 am
Tags:
China, Ipsen
Baxter snags hemophilia candidate in $185M deal with Ipsen and broke biotech
Fierce Biotech
Thu, 01/24/13 - 11:32 am
Tags:
Baxter International, Ipsen, hemophilia
Roche Said to Return Diabetes Drug Rights to Ipsen
Bloomberg
Tue, 02/1/11 - 08:25 am
Tags:
Ipsen, Roche, diabetes, taspoglutide
The Top 10 Phase III Failures of 2010
Fierce Biotech
Fri, 10/22/10 - 11:36 am
Tags:
clinical trials, dimebon, Medivation, Pfizer, ocrelizumab, Roche, rheumatoid arthritis, taspoglutide, diabetes, Ipsen, semagacestat, Eli Lilly, ASA404, Antisoma, Novartis, Novelos Therapeutics, AstraZeneca, zibotentan, vicriviroc, Merck, Recentin, Vical, Sanofi

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.